Cost-benefit analysis of introducing next-generation sequencing (metagenomic) pathogen testing in the setting of pyrexia of unknown origin

• المؤلفون الرئيسيون: Chai J.H., Lee C.K., Lee H.K., Wong N., Teo K., Tan C.S., Thokala P., Tang J.W.-T., Tambyah P.A., Oh V.M.S., Loh T.P., Yoong J.
• مؤلفون آخرون: CENTRE FOR MOLECULAR EPIDEMIOLOGY
• التنسيق: مقال
• منشور في: 2019
• الموضوعات: Article; cost benefit analysis; decision making; diagnostic cost; diagnostic test; diagnostic value; feasibility study; health care system; health economics; human; metagenomics; next generation sequencing; probability; pyrexia idiopathica; sensitivity analysis; Singapore; bacterium; economics; fever; genetics; high throughput sequencing; microbiology; Bacteria; Cost-Benefit Analysis; Fever; High-Throughput Nucleotide Sequencing; Humans; Metagenomics
• الوصول للمادة أونلاين: https://scholarbank.nus.edu.sg/handle/10635/161234

10.1371/journal.pone.0194648